Table of Contents
<< Previous Issue | Dec 2010 (Vol: 2010, Issue: 10) | Next Issue >> |
- Section: Licensing
-
Mesoblast and Cephalon in Largest Regenerative Medicine Deal to Date
- Section: Mergers & Acquisitions
-
BTG Strengthens its Speciality Portfolio with Biocompatibles Acquisition
-
Hikma Pharmaceuticals Reinforces its Global Portfolio with Purchase of Baxter Healthcare’s US Generic Injectables Business
-
Kadmon Pharmaceuticals Signs Three Hepatitis C Deals
-
Axcan Offers to Acquire Eurand to Accelerate its Speciality Pharma Business
-
Merck & Co. to Acquire SmartCells and its Glucose-Responsive Insulin Technology
-
GlaxoSmithKline Expands into China with Nanjing MeiRui Pharma Acquisition
- Section: Research & Development
-
GE Healthcare and Janssen to Develop Biosignatures for Alzheimer’s Disease